Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02700711 · ClinicalTrials.gov registry record · Phase 1
Methylphenidate-Duloxetine Combinations for Cocaine Dependence
A Phase 1 study, sponsored by University of Kentucky.
- Completed
- Registry status
- Phase 1
- Development phase
- 13
- Enrollment target
NCT02700711 is a Phase 1 study that has completed, run by University of Kentucky. The registered enrollment target is 13 participants.
The verdict
NCT02700711, a Phase 1 study, has completed, sponsored by University of Kentucky.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 13 participants
- Enrollment target
Study Summary
This study will determine the influence of methylphenidate (e.g., Ritalin®) and duloxetine (Cymbalta®), alone and in combination, on the cocaine use as measured by self-report and urine drug screens.
Interventions
- DRUG Placebo
- DRUG Duloxetine
- DRUG Methylphenidate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2016-02 |
| Est. Completion | 2018-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02700711
The ClinicalTrials.gov registry entry for NCT02700711 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kentucky, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT02700711 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02700711 about?
NCT02700711 is a clinical study titled "Methylphenidate-Duloxetine Combinations for Cocaine Dependence". This study will determine the influence of methylphenidate (e.g., Ritalin®) and duloxetine (Cymbalta®), alone and in combination, on the cocaine use as measured by self-report and urine drug screens.
What is the current status of trial NCT02700711?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 13 participants. The study started on 2016-02. Estimated completion is 2018-06.
What interventions are being tested in trial NCT02700711?
The interventions under investigation include: Placebo (DRUG), Duloxetine (DRUG), Methylphenidate (DRUG).
Who is sponsoring clinical trial NCT02700711?
This trial is sponsored by University of Kentucky, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.